Maninder Bedi, MD
Cardiovascular Disease · Weirton, WVNPI 1003851213
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $142,700 of the $230,220 with a category attached, or 62.0%. Medtronic accounts for 64.4% of it on its own, with 37 other manufacturers making up the rest. Reporting peaked in 2019 at $84,182 and has fallen 94.6% since, to $4,566 in 2025. Among cardiovascular disease clinicians in WV with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 670 payments — averaging $343.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$148K
- Boston Scientific$38K
- Baylis Medical Company Inc$12K
- Abbott$10K
- Biosense Webster, Inc.$10K
- Biotronik Inc.$5K
- plus $8K from 32 others
Across 42 payments — averaging $2440.50 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Boston Scientific$88K
- Impulse Dynamics (USA) Inc.$13K
- Biotronik Inc.$1K
What the payments were for
- Consulting fees$22,33210%
- Speaking & faculty fees$142,70062%
- Travel & lodging$40,95218%
- Food & beverage$24,23011%
- Education$60%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 230 | $148,219 |
| Boston Scientific | 172 | $38,289 |
| Baylis Medical Company Inc | 8 | $11,561 |
| Abbott | 98 | $10,190 |
| Biosense Webster, Inc. | 15 | $9,529 |
| Biotronik Inc. | 20 | $4,766 |
| Sanofi-aventis U.S. LLC | 6 | $2,660 |
| Impulse Dynamics (USA) Inc. | 8 | $708 |
| Cook Incorporated | 2 | $704 |
| Kestra Medical Technology Services, Inc. | 11 | $618 |
| Atricure, Inc. | 5 | $526 |
| Irhythm Technologies, Inc. | 5 | $369 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 15 | $321 |
| E.r. Squibb & Sons, L.L.C. | 18 | $305 |
| AstraZeneca | 5 | $163 |
| Johnson & Johnson | 9 | $127 |
| Cook Medical LLC | 1 | $124 |
| Cvrx, Inc. | 4 | $121 |
| ZOLL Respicardia, Inc. | 1 | $118 |
| Edwards Lifesciences | 4 | $99 |
| Pfizer | 5 | $97 |
| Vektor Medical Inc. | 1 | $89 |
| Boehringer Ingelheim | 5 | $86 |
| Elutia, Inc. | 2 | $54 |
| Scpharmaceuticals Inc. | 3 | $52 |
| Alnylam Pharmaceuticals Inc. | 2 | $47 |
| Heartflow, Inc. | 1 | $42 |
| Novartis | 2 | $38 |
| Amgen | 2 | $30 |
| Shockwave Medical, Inc | 2 | $27 |
| Esperion Therapeutics, Inc. | 1 | $21 |
| Cardiva Medical, Inc. | 1 | $21 |
| Novo Nordisk | 1 | $19 |
| United Therapeutics Corporation | 1 | $19 |
| Merck | 1 | $18 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $16 |
| Bayer | 1 | $16 |
| Amarin Pharma, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Arctic Front$45,434
- GENERAL - THERAPIES$29,968
- Carto 3 System$9,012
- Carto Smarttouch$8,898
- Carto CFAE$8,898
- CartoSound$8,898
- InSync$8,421
- VersaCross Access Solution$3,462
- NRG needle$3,000
- VersaCross$3,000
- ACUITY$2,800
- Confirm Rx$2,750
- DISEASE STATE$2,544
- ENSITE PRECISION$2,278
- AVEIR$1,843
- Micra$1,436
- Watchman$1,130
- DiamondTemp$1,083
- WATCHMAN Access System$794
- Cook Medical Lead Management$704
How this compares
$230,220 in reported general payments places this provider in the 95th percentile of 100 cardiovascular disease providers in West Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 1,350 | $1,127,639 |
| XareltoRivaroxaban | 376 | $332,525 |
| Dofetilide | 598 | $115,643 |
| Propafenone Hcl ErPropafenone Hcl | 389 | $65,758 |
| EntrestoSacubitril/Valsartan | 40 | $41,280 |
| MultaqDronedarone Hcl | 33 | $32,716 |
| Flecainide Acetate | 544 | $19,071 |
| Amiodarone Hcl | 1,094 | $17,158 |
| Mexiletine Hcl | 142 | $11,688 |
| Metoprolol Succinate | 1,019 | $10,202 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 246 | $6,265 |
| Propafenone Hcl | 110 | $4,999 |
| Verapamil SrVerapamil Hcl | 44 | $4,215 |
| SotalolSotalol Hcl | 208 | $3,878 |
| Midodrine Hcl | 55 | $2,939 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $97 | $1,127,6391,350 claims |
| Johnson & JohnsonXarelto | $127 | $332,525376 claims |
| NovartisEntresto | $38 | $41,28040 claims |
| Sanofi-aventis U.S. LLCMultaq | $2,660 | $32,71633 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 100 cardiovascular disease providers in West Virginia.
Other cardiovascular disease in Weirton
- Daniel JovanovichWeirton$18K
- Sarah RinehartCharleston$303K
- Partho SenguptaMorgantown$131K
- Kofi OseiHuntington$87K
- Esam BaryunHuntington$55K
- Mohammad YousafSouth Charleston$34K
- Madhavi KadiyalaMorgantown$29K
- Rameez SayyedHuntington$21K
- David CampseyMorgantown$21K
- Casey HagerSouth Charleston$20K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.